Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cardiovascular Drugs and Therapy|February 1, 1990
A double-blind comparison of bisoprolol and captopril for treatment of essential hypertension in the elderlyD Bracchetti, R Gradnik, A Alberti, et al.
European Heart Journal|November 1, 1990
Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover studyP Sangiorgio, G Di Pasquale, S Savonitto, et al.
Cardiologia (Rome, Italy)|June 1, 1995
[Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up]G Boriani, L Frabetti, A Capucci, et al.
Giornale Italiano Di Cardiologia|December 1, 1996
[ST segment depression during recovery after treadmill exercise test in stable patients with previous myocardial infarction]G Casella, P C Pavesi, M Di Niro, et al.
Minerva Cardioangiologica|December 6, 2001
Outcome of percutaneous coronary angioplasty (PTCA) performed in a low-volume institution by low-volume operators, evaluated by means of the one-month major adverse cardiac event rateA Rubboli, R Brancaleoni, D E Euler, et al.
Minerva Medica|September 1, 1980
[Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses]A Martoni, G Pedelini, G Colalongo, et al.
Giornale Italiano Di Cardiologia|August 1, 1986
[Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias]D Bracchetti, F Naccarella, R F Guaragna, et al.
International Journal of Clinical Pharmacology Research|January 1, 1991
A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexesA Capucci, G Di Pasquale, G Boriani, et al.
The International Journal of Artificial Organs|April 21, 2001
A semi-automatic algorithm for reducing the time spent on routine follow-up of cardioverter defibrillatorsG Boriani, M Biffi, R Renzi, et al.
JAMA|March 14, 1986
Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter studyJ Wikstrand, G Westergren, G Berglund, et al.
Pageof 8